NCT02415283Unknown不适用
Evaluation of the Capability of the ¹³C-Octanoate Breath Test (OBT) Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI in Patients With Chronic Liver Disease
Beijing 302 Hospital0 个研究点目标入组 2 人开始时间: 2015年5月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 2
- 主要终点
- 13CO2/12CO2 ratio
研究概览
简要总结
The Exalenz clinical investigation is a multicenter, non-randomized, study of the ¹³C-Octanoate Breath Test (OBT). The present study is a feasibility trial, which aims to evaluate the capability of the OBT to differentiate between presence and absence of HCC determined by Magnetic Resonance Imaging (MRI) in patients with chronic liver disease.
详细描述
- Informed consent will be obtained from all patients prior to enrollment.
- The trial will be conducted in compliance with this protocol, with GCP standards, and the applicable regulatory requirements.
- This study will be cross-sectional, where patients will be enrolled on a walk in basis. Once one arm is completed the other one will be enriched in order to obtain at least 50 positive and at least 50 negative HCC subjects as defined by MRI.
- All patients will undergo AFP and US if they do not have results within the past three months.
- If the patient undergoes liver FNA, the biopsy results will be evaluated for the presence of HCC.
- For all patients, a case report form will be completed.
- All patients will undergo a physical examination, and their medical history/concomitant medications, weight, height and age will be recorded. Furthermore, recent (past 3 months) blood test results, if available, may be recorded.
- If relevant (woman of child bearing age), a pregnancy test will be performed to rule out pregnancy when performing the breath test.
- All MRI negative patients with low OBT results will undergo additional MRI within 6 to 12 months post OBT to rule out HCC occurrence.
- If available, all additional MRI/CT/US results will be recorded within the patient's CRF.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Any patients with chronic liver disease at risk for HCC.
- •Age ≥ 18 years.
- •Patient has an MRI result (positive or negative for HCC) up to 3 months prior to recruitment or will be scheduled for an MRI during the trial period.
- •Patient is naïve to HCC treatment (RFA or TACE or Oral HCC treatments) since last MRI.
排除标准
- •Any patients with chronic liver disease at risk for HCC.
- •Age ≥ 18 years.
- •Patient has an MRI result (positive or negative for HCC) up to 3 months prior to recruitment or will be scheduled for an MRI during the trial period.
- •Patient is naïve to HCC treatment (RFA or TACE or Oral HCC treatments) since last MRI.
- •Patients currently receiving total parenteral nutrition if they have contraindications to oral drugs.
- •Women who are pregnant or breast feeding.
- •Patient taking drugs that can interfere with octanoate metabolism or can also cause NAFLD independent of the metabolic syndrome, including: corticosteroids, amiodarone, tetracycline, valproic acid, methotrexate, stavudine, zidovudine.
- •Patient, based on the opinion of the investigator, should not be enrolled into this study.
- •Patient unable or unwilling to sign informed consent.
- •Patients that are participating in other clinical trials evaluating experimental treatments or procedures
结局指标
主要结局
13CO2/12CO2 ratio
时间窗: 60min
次要结局
未报告次要终点
研究者
Yongping Yang
Director of Department
Beijing 302 Hospital
相似试验
终止
2 期
Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRIChronic Liver DiseaseHepatocellular Carcinoma (HCC)NCT01433016Meridian Bioscience, Inc.20
已完成
2 期
A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on DialysisChronic Kidney Disease Requiring Chronic DialysisNCT06218290Unicycive Therapeutics, Inc106
已完成
3 期
Fast-track LiveR: Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-testLiver FailureNCT01785082Humedics GmbH149
已完成
2 期
Determination of HCC With Octanoate Breath Test vs. MRI DiagnosisHepatocellular Carcinoma (HCC)NCT02794805Meridian Bioscience, Inc.74
招募中
2 期
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCDSickle Cell DiseaseNCT05431088Pfizer389